{"id":12717,"date":"2026-07-21T12:26:38","date_gmt":"2026-07-21T10:26:38","guid":{"rendered":"https:\/\/www.kalliope-law.com\/?p=12717"},"modified":"2026-07-21T12:26:16","modified_gmt":"2026-07-21T10:26:16","slug":"press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories","status":"publish","type":"post","link":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/","title":{"rendered":"Press Release &#8211; Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"12717\" class=\"elementor elementor-12717 elementor-12708\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-71aa404 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"71aa404\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-be028c5\" data-id=\"be028c5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-00451aa elementor-widget elementor-widget-text-editor\" data-id=\"00451aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400;\">Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.<\/p><p style=\"font-weight: 400;\">Founded in 2010, PathoQuest is a pioneer and global leader in next-generation sequencing-based biosafety testing. The company develops innovative biosafety testing solutions for biotherapies, vaccines and advanced biological products.<\/p><p style=\"font-weight: 400;\">Originally spun out from Institut Pasteur, PathoQuest has been backed since its early days by Kurma Partners, later joined by Eurazeo and Aurinvest. The transaction represents a new strategic milestone in the company\u2019s development.<\/p><p style=\"font-weight: 400;\">The Kalliop\u00e9 team advising on the corporate\/M&amp;A aspects of the transaction comprised <a href=\"https:\/\/www.kalliope-law.com\/en\/lawyer\/alexia-berbain-faguer\/\">Alexia Berbain-Faguer<\/a> (partner) and <a href=\"https:\/\/www.kalliope-law.com\/en\/lawyer\/ava-sereshki\/\">Ava Sereshki<\/a> (associate).<\/p><p style=\"font-weight: 400;\">Photo credit: Marvin Radke<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories. Founded in 2010, PathoQuest is a pioneer and global leader in next-generation sequencing-based biosafety testing. The company develops innovative biosafety testing solutions for biotherapies, vaccines and advanced biological products. Originally spun out from Institut Pasteur, PathoQuest [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":12710,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[111,107,105],"tags":[],"class_list":["post-12717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-m-and-a-private-equity","category-expertise","category-press"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope<\/title>\n<meta name=\"description\" content=\"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope\" \/>\n<meta property=\"og:description\" content=\"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/\" \/>\n<meta property=\"og:site_name\" content=\"Kalliope\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T10:26:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kalliop\u00e9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@kalliopelaw\" \/>\n<meta name=\"twitter:site\" content=\"@kalliopelaw\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kalliop\u00e9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/\"},\"author\":{\"name\":\"Kalliop\u00e9\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#\\\/schema\\\/person\\\/b380de41cd82bc5538aaa24ae5a305d2\"},\"headline\":\"Press Release &#8211; Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories\",\"datePublished\":\"2026-07-21T10:26:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/\"},\"wordCount\":130,\"publisher\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg\",\"articleSection\":[\"CORPORATE \u2013 M&amp;A \u2013 PRIVATE EQUITY\u00a0\",\"Expertise\",\"Press\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/\",\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/\",\"name\":\"Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg\",\"datePublished\":\"2026-07-21T10:26:38+00:00\",\"description\":\"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Release &#8211; Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/\",\"name\":\"Kalliope\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#organization\",\"name\":\"Kaliiop\u00e9\",\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/logo-kalliope.svg\",\"contentUrl\":\"https:\\\/\\\/www.kalliope-law.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/logo-kalliope.svg\",\"width\":189,\"height\":42,\"caption\":\"Kaliiop\u00e9\"},\"image\":{\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/kalliopelaw\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kalliopelaw\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/#\\\/schema\\\/person\\\/b380de41cd82bc5538aaa24ae5a305d2\",\"name\":\"Kalliop\u00e9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g\",\"caption\":\"Kalliop\u00e9\"},\"url\":\"https:\\\/\\\/www.kalliope-law.com\\\/en\\\/author\\\/kalliope-law\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope","description":"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/","og_locale":"en_US","og_type":"article","og_title":"Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope","og_description":"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.","og_url":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/","og_site_name":"Kalliope","article_published_time":"2026-07-21T10:26:38+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg","type":"image\/jpeg"}],"author":"Kalliop\u00e9","twitter_card":"summary_large_image","twitter_creator":"@kalliopelaw","twitter_site":"@kalliopelaw","twitter_misc":{"Written by":"Kalliop\u00e9","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#article","isPartOf":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/"},"author":{"name":"Kalliop\u00e9","@id":"https:\/\/www.kalliope-law.com\/en\/#\/schema\/person\/b380de41cd82bc5538aaa24ae5a305d2"},"headline":"Press Release &#8211; Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories","datePublished":"2026-07-21T10:26:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/"},"wordCount":130,"publisher":{"@id":"https:\/\/www.kalliope-law.com\/en\/#organization"},"image":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg","articleSection":["CORPORATE \u2013 M&amp;A \u2013 PRIVATE EQUITY\u00a0","Expertise","Press"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/","url":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/","name":"Press Release - Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories - Kalliope","isPartOf":{"@id":"https:\/\/www.kalliope-law.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#primaryimage"},"image":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg","datePublished":"2026-07-21T10:26:38+00:00","description":"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories.","breadcrumb":{"@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#primaryimage","url":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg","contentUrl":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.kalliope-law.com\/en\/press-release-kalliope-advises-kurma-partners-eurazeo-and-aurinvest-on-the-sale-of-their-stake-in-pathoquest-to-charles-river-laboratories\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.kalliope-law.com\/en\/"},{"@type":"ListItem","position":2,"name":"Press Release &#8211; Kalliop\u00e9 advises Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories"}]},{"@type":"WebSite","@id":"https:\/\/www.kalliope-law.com\/en\/#website","url":"https:\/\/www.kalliope-law.com\/en\/","name":"Kalliope","description":"","publisher":{"@id":"https:\/\/www.kalliope-law.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kalliope-law.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.kalliope-law.com\/en\/#organization","name":"Kaliiop\u00e9","url":"https:\/\/www.kalliope-law.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kalliope-law.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2022\/04\/logo-kalliope.svg","contentUrl":"https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2022\/04\/logo-kalliope.svg","width":189,"height":42,"caption":"Kaliiop\u00e9"},"image":{"@id":"https:\/\/www.kalliope-law.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/kalliopelaw","https:\/\/www.linkedin.com\/company\/kalliopelaw\/"]},{"@type":"Person","@id":"https:\/\/www.kalliope-law.com\/en\/#\/schema\/person\/b380de41cd82bc5538aaa24ae5a305d2","name":"Kalliop\u00e9","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cf2f8ef469f5aeaa4ec3eb7180b06ab4e09b6c209ed4534611eb81d14d737fff?s=96&d=mm&r=g","caption":"Kalliop\u00e9"},"url":"https:\/\/www.kalliope-law.com\/en\/author\/kalliope-law\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-scaled.jpg",2560,1707,false],"thumbnail":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-150x150.jpg",150,150,true],"medium":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-768x512.jpg",768,512,true],"large":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-1024x683.jpg",800,534,true],"1536x1536":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/www.kalliope-law.com\/wp-content\/uploads\/2026\/07\/marvin-radke-Y-Qp-YACSBk-unsplash-2048x1365.jpg",2048,1365,true]},"uagb_author_info":{"display_name":"Kalliop\u00e9","author_link":"https:\/\/www.kalliope-law.com\/en\/author\/kalliope-law\/"},"uagb_comment_info":0,"uagb_excerpt":"Kalliop\u00e9 advised Kurma Partners, Eurazeo and Aurinvest on the sale of their stake in PathoQuest to Charles River Laboratories. Founded in 2010, PathoQuest is a pioneer and global leader in next-generation sequencing-based biosafety testing. The company develops innovative biosafety testing solutions for biotherapies, vaccines and advanced biological products. Originally spun out from Institut Pasteur, PathoQuest&hellip;","_links":{"self":[{"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/posts\/12717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/comments?post=12717"}],"version-history":[{"count":4,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/posts\/12717\/revisions"}],"predecessor-version":[{"id":12721,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/posts\/12717\/revisions\/12721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/media\/12710"}],"wp:attachment":[{"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/media?parent=12717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/categories?post=12717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kalliope-law.com\/en\/wp-json\/wp\/v2\/tags?post=12717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}